Live Breaking News & Updates on Singapore Health Sciences Authority

Stay updated with breaking news from Singapore health sciences authority. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Junshi Biosciences Announces NDA Acceptance in Hong Kong

SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading. ....

United States , United Kingdom , San Francisco , Hong Kong Special Administrative Region , Hong Kong General , Hong Kong , South Africa , Zhi Li , Junshi Biosciences , American Society Of Clinical Oncology , National Reimbursement Drug List , Drug Office , Department Of Health , Ir Team , European Union , Australia Therapeutic Goods Administration , Singapore Health Sciences Authority , Journal Of The American Medical Association , Pr Team , Shanghai Junshi Biosciences Co Ltd , World Health Organization , European Medicines Agency , New Drug Application , Clinical Oncology , Nature Medicine , American Medical Association ,

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong Kong Special Administrative Region , Hong Kong General , Hong Kong , South Africa , San Francisco , United States , United Kingdom , Junshi Biosciences , Zhi Li , Dennis Riedl , Ir Team , Australia Therapeutic Goods Administration , European Union , American Society Of Clinical Oncology , Journal Of The American Medical Association , World Health Organization , Singapore Health Sciences Authority , Department Of Health , European Medicines Agency , Shanghai Junshi Biosciences Co Ltd , Drug Office , Pr Team , National Reimbursement Drug List , New Drug Application , Clinical Oncology , Nature Medicine ,

FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer

FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , South San Francisco , Ken Culver , Levi Garraway , Israel Ministry Of Health Imoh Pharmaceutical Administration , Brazil National Health Surveillance Agency , Healthcare Products Regulatory Agency United Kingdom , European Medicines Agency , Australian Therapeutics Goods Administration , American Cancer Society , Roche Group , Health Canada , National Comprehensive Cancer Network , Drug Administration , Clinical Affairs , Global Product Development , Singapore Health Sciences Authority , Global Product , New England Journal , National Comprehensive Cancer , Clinical Practice Guidelines , Pharmaceutical Administration , Healthcare Products Regulatory Agency , National Health Surveillance Agency , Health Sciences Authority ,

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer By Investing.com

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer By Investing.com
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Pabout Toripalimab , Junshi Bioscienceszhi , Junshi Biosciences , Singapore Health Sciences Authority , University Cancer Hospital , Junshi Biosciences Contact Informationir Team , European Medicines Agency , Australia Therapeutic Goods Administration , International Metastatic Renal Cell Carcinoma Database Consortium , Pr Team , National Medical Products Administration , Shanghai Junshi Biosciences Co Ltd , National Reimbursement Drug List , Professor Jun , Peking University Cancer Hospital , Professor Yiran , Renji Hospital Affiliated , Shanghai Jiao Tong University School , Independent Review Committee , Proffered Paper Session , European Society , Medical Oncology , Southeast Asia , Biologics License Application ,

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Junshi Biosciences , Zhi Li , Australia Therapeutic Goods Administration , Shanghai Junshi Biosciences Co Ltd , University Cancer Hospital , Ir Team , Pr Team , Singapore Health Sciences Authority , International Metastatic Renal Cell Carcinoma Database Consortium , National Reimbursement Drug List , National Medical Products Administration , European Medicines Agency , Biosciences Announces Approval , Line Treatment , Professor Jun , Peking University Cancer Hospital , Professor Yiran , Renji Hospital Affiliated , Shanghai Jiao Tong University School , Independent Review Committee , Proffered Paper Session , European Society , Medical Oncology , Southeast Asia ,